The European Bank for Reconstruction and Development (EBRD) has provided JSC Farmak (Kyiv) with a loan of EUR 20 million to replenish working capital, according to a press release from the EBRD.
"The EBRD is lending EUR 20 million to a leading Ukrainian pharmaceuticals manufacturer, JSC Farmak, under its EUR 2 billion Resilience and Livelihoods Framework supporting countries affected by the war in Ukraine," the report says.
The program provides for the sustainability and preservation of livelihoods and support for countries affected by the war in Ukraine.
According to the EBRD, the total amount of the Program is EUR 2 billion.
The EBRD reports that this loan has a 5.5% first loss guarantee under the EBRD's Shareholder Special Fund Risk Sharing Programme. Thus, the total donor guarantee will cover 50% of the loan amount.
Advertising
Advertising
MORE ABOUT
EBRD provides Credit Agricole Bank EUR 150 mln guarantee for business lending
09:57, 03.12.2025
EBRD to provide Ukrhydroenergo EUR 75 mln, expects additional EUR 20 mln in investment grants
20:34, 02.12.2025
EBRD provides guarantee for Ukrsibbank loan to develop EVA logistics hubs
13:36, 26.11.2025
Ukrainian pharma manufacturers lose 3-5% of revenues due to state regulation – expert
11:10, 18.11.2025
IFC and EBRD co-invest $25 mln in Dragon Capital's Rebuild Ukraine Fund
11:55, 14.11.2025
LATEST
Ukraine's State Agency revises claims about UAH 6.6 bln road through Bukovel
20:30, 05.12.2025
G7, EU countries considering complete ban on oil transportation from Russia instead of price cap – media
20:29, 05.12.2025
Intl support for humanitarian demining since 2022 reaches nearly $1.5 bln – Economy Minister
19:42, 05.12.2025
Eighty-three candidates apply for four Energoatom Supervisory Board seats
14:02, 05.12.2025
Vodafone Ukraine announces another buy-out of eurobonds for $1.16 mln